ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Financings
Financings
| Raise | Date |
|---|---|
| At-the-market programme of common stock Closed: US$20M raised | Feb 23, 2026 |
| At-the-market programme of common stock Closed: US$119M raised | Aug 12, 2025 |
| Private placement of common stock (or pre-funded warrants in lieu thereof) Announced: about US$125M · US$6.5 a share Buyers: SR One (leads the financing); Point72; Viking Global Investors; Venrock Healthcare Capital Partners; NEA; Nextech; Vivo Capital; NEXTBio Capital Use of proceeds: Research and development of clinical-stage product candidates and research programs, working capital and general corporate purposes | May 28, 2025 |